Ji Hyoung Kim (Jee Hung Kim)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Topics

Sentinel Lymph Node

Estrogen Receptor

Neoadjuvant Chemotherapy

Top Venues

Yonsei medical journal

Journal of breast cancer

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Gowoon Yang, Jun Won Kim, Ik Jae Lee, Joon Jeong, Sung-Gwe Ahn, Soong June Bae, Ji Hyoung Kim, Yeona Cho
Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy. Yonsei medical journal 65 (3) (2024)
Jeongshim Lee, Ji Hyoung Kim, Mitchell Liu, Andrew Bang, Robert J Olson, Jee Suk Chang
Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer. Journal of breast cancer 27 (2) (2024)
Min Ji Kim, Na Lae Eun, Sung-Gwe Ahn, Ji Hyoung Kim, Ji Hyun Youk, Eun Ju Son, Joon Jeong, Yoon-Jin Cha, Soong June Bae
Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers 16 (2) (2024)
Soong June Bae, Ji Hyoung Kim, Min Ji Lee, Seung Ho Baek, Yoonwon Kook, Sung-Gwe Ahn, Yoon-Jin Cha, Joon Jeong
Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade. Cancers 16 (4) (2024)
Jeongshim Lee, Ji Hyoung Kim, Mitchell Liu, Andrew Bang, Robert J Olson, Jee Suk Chang
Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer. Journal of breast cancer 27 (2) (2024)
Gowoon Yang, Jun Won Kim, Ik Jae Lee, Joon Jeong, Sung-Gwe Ahn, Soong June Bae, Ji Hyoung Kim, Yeona Cho
Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy. Yonsei medical journal 65 (3) (2024)
Jeongshim Lee, Ji Hyoung Kim, Mitchell Liu, Andrew Bang, Robert J Olson, Jee Suk Chang
Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer. Journal of breast cancer (2024)
Na Lae Eun, Soong June Bae, Ji Hyun Youk, Eun Ju Son, Sung-Gwe Ahn, Joon Jeong, Ji Hyoung Kim, Yangkyu Lee, Yoon-Jin Cha
Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancer. Cancers 16 (7) (2024)
Min Ji Kim, Na Lae Eun, Sung-Gwe Ahn, Ji Hyoung Kim, Ji Hyun Youk, Eun Ju Son, Joon Jeong, Yoon-Jin Cha, Soong June Bae
Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers 16 (2) (2024)
Jeongshim Lee, Ji Hyoung Kim, Mitchell Liu, Andrew Bang, Robert J Olson, Jee Suk Chang
Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer. Journal of breast cancer 27 (2) (2024)
Jeongshim Lee, Ji Hyoung Kim, Mitchell Liu, Andrew Bang, Robert J Olson, Jee Suk Chang
Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer. Journal of breast cancer 27 (2) (2024)
Na Lae Eun, Soong June Bae, Ji Hyun Youk, Eun Ju Son, Sung-Gwe Ahn, Joon Jeong, Ji Hyoung Kim, Yangkyu Lee, Yoon-Jin Cha
Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancer. Cancers 16 (7) (2024)
Gowoon Yang, Jun Won Kim, Ik Jae Lee, Joon Jeong, Sung-Gwe Ahn, Soong June Bae, Ji Hyoung Kim, Yeona Cho
Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy. Yonsei medical journal 65 (3) (2024)
Na Lae Eun, Soong June Bae, Ji Hyun Youk, Eun Ju Son, Sung-Gwe Ahn, Joon Jeong, Ji Hyoung Kim, Yangkyu Lee, Yoon-Jin Cha
Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancer. Cancers 16 (7) (2024)
Soong June Bae, Ji Hyoung Kim, Min Ji Lee, Seung Ho Baek, Yoonwon Kook, Sung-Gwe Ahn, Yoon-Jin Cha, Joon Jeong
Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade. Cancers 16 (4) (2024)
Gowoon Yang, Jun Won Kim, Ik Jae Lee, Joon Jeong, Sung-Gwe Ahn, Soong June Bae, Ji Hyoung Kim, Yeona Cho
Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy. Yonsei medical journal 65 (3) (2024)
Soong June Bae, Sung-Gwe Ahn, Eun Ji Park, Na Lae Eun, Ji Hyoung Kim, Jung Hwan Ji, Yoonwon Kook, Ji Soo Jang, Seung Ho Baek, Yoon-Jin Cha, Joon Jeong
Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing Mastectomy. Radiology (2023)
Inho Park, Yangkyu Lee, Ji Hyoung Kim, Soong June Bae, Sung-Gwe Ahn, Joon Jeong, Yoon-Jin Cha
YAP1 Expression in HR+HER2- Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation. Cancers 15 (20) (2023)
Hyungwook Choi, Sung-Gwe Ahn, Soong June Bae, Ji Hyoung Kim, Na Lae Eun, Yangkyu Lee, Ji-Hae Nahm, Joon Jeong, Yoon-Jin Cha
Comparison of Programmed Cell Death Ligand 1 Status between Core Needle Biopsy and Surgical Specimens of Triple-Negative Breast Cancer. Yonsei medical journal 64 (8) (2023)
Jung Hwan Ji, Soong June Bae, Kyungsoo Kim, Chihhao Chu, Kyung-A Lee, Yoonjung Kim, Ji Hyoung Kim, Joon Jeong, Sung-Gwe Ahn
Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer. NPJ breast cancer 8 (1) (2022)
Seung Ho Baek, Ji Hyoung Kim, Soong June Bae, Jung Hwan Ji, Yangkyu Lee, Joon Jeong, Yoon-Jin Cha, Sung-Gwe Ahn
SP142 PD-L1 Assays in Multiple Samples from the Same Patients with Early or Advanced Triple-Negative Breast Cancer. Cancers 14 (13) (2022)
Jung Hwan Ji, Soong June Bae, Seul-Gi Kim, Min Hwan Kim, Gun-Min Kim, Joohyuk Sohn, Joon Jeong, Ji Hyoung Kim, Sung-Gwe Ahn
Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP. Cancer medicine (2022)
Chang Gon Kim, Nam Suk Sim, Jeong Eun Kim, Kum-Hee Yun, Young Han Lee, Seung Hyun Kim, Wooyeol Baek, Yoon Dae Han, Sang Kyum Kim, Ji Hyoung Kim, Yoon Woo Koh, Inkyung Jung, Su-Jin Shin, Sun Young Rha, Jin-Hee Ahn, Hyo Song Kim
Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Sun Min Lim, Eunyoung Kim, Kyung Hae Jung, Sora Kim, Ja Seung Koo, Seung Il Kim, Seho Park, Hyung Seok Park, Byoung Woo Park, Young Up Cho, Ji Ye Kim, Soonmyung Paik, Nak-Jung Kwon, Gun Min Kim, Ji Hyoung Kim, Min Hwan Kim, Min Kyung Jeon, Sangwoo Kim, Joo Hyuk Sohn
Genomic landscape of extraordinary responses in metastatic breast cancer. Communications biology 4 (1) (2021)
Byung Min Lee, Yeona Cho, Jun Won Kim, Sung-Gwe Ahn, Ji Hyoung Kim, Hei Cheul Jeung, Joon Jeong, Ik Jae Lee
Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer. Cancers 13 (8) (2021)
Beung Chul Ahn, Ji Hyoung Kim, Kyoung-Ho Pyo, Sun Min Lim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho
Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study. Cancers 13 (15) (2021)
Min Hee Hong, Hye Ryun Kim, Beung Chul Ahn, Su Jin Heo, Ji Hyoung Kim, Byoung Chul Cho
Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer. Yonsei medical journal 60 (6) (2019)